The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, involves a complex multi-step synthetic process. Early routes focused on peptide portion coupling, utilizing solid-phase https://nettiexezq520568.blogcudinti.com/40852982/production-and-study-implementations-of-retatrutide